First Choice Healthcare Solutions, Inc. (FCHS): Cash & Equivalents
$5.9K
As of 2025-12-31
$6.8K
As of 2026-06-30
-6.5%
3-year compound annual growth
-42.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.9K | -70.4% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $19.9K | +58.0% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $12.6K | +74.6% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $7.2K | n/a | 2024-05-13, Balance as of period end |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | $2.02M | -56.1% | 2018-04-03, Balance as of period end |
| 2016-12-31 | $4.59M | +188.0% | 2018-04-03, Balance as of period end |
| 2015-12-31 | $1.59M | +471.5% | 2017-04-03, Balance as of period end |
| 2014-12-31 | $279.1K | -62.2% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $739.2K | n/m | 2015-04-15, Balance as of period end |
| 2012-12-31 | $67.0K | -87.3% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $528.3K | n/m | 2013-04-01, Balance as of period end |
| 2010-12-31 | $3.3K | n/a | 2012-03-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $5.9K | -70.4% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $2.49M | -13.9% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $12.02M | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | $6.01M | +91.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $531.3K | -59.5% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $3.46M | -68.6% |
| Exagen Inc. (XGN) | 2025-12-31 | $32.22M | +46.2% |
| Ludwig Enterprises, Inc. (LUDG) | 2025-12-31 | $0 | -100.0% |
| Biodesix Inc (BDSX) | 2025-12-31 | $18.99M | -27.7% |
Compare FCHS, BGLC, ACON, YDES side by side · Screen every company in Services-Medical Laboratories ↗